Clinical trial · Observational
Computertomography-guided Wire Marking of the Liver
Computertomography-guided Wire Marking of Colorectal Hepatic Metastases After Complete Response to Neoadjuvant Chemotherapy. A Pilot Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of the study is to evaluate if it is possible to mark with a wire colorectal hepatic metastases after complete response to a neoadjuvant chemotherapy.Primary the investigators want to investigate if the wire marking is a possibility to mark respectively to identify these lesions. Further the investigators want to evaluate how many patients with complete radiologic have complete histologic response in their specimen respectively in how many specimens in the definitive histology tumor cells are visible.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Secondary Malignant Neoplasm of Liver | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Computertomography-guided marking of colorectal liver metastases | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Marking Liver
- interventionNames
- Procedure: Computertomography-guided marking of colorectal liver metastases
Primary outcomes (1)
- measure
- Sensitivity
- timeFrame
- One Year
- description
- Sensitivity of wire marking to find liver metastases with complete response to neoadjuvant chemotherapy
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Histologic verified cancer of the colon and rectum with metastases into the liver * Neoadjuvant chemotherapy with complete radiologic response of metastases in apparative diagnostic respectively metastases with a diameter ≤ 1 cm. * Technically Resectability * Age ≥ 18 Years * Written informed consent Exclusion Criteria: * Age \< 18 Years * Technically Irresectability * Neoadjuvant chemotherapy and response of metastases, however with a diameter \> 1 cm.
References
Publications (0)
Data not yet available